Hyperlipidemia in hypertension: causes and prevention

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Pharmacology

Background:

• Hyperlipidemia is common in hypertension patients, but the underlying cause remains unclear.
• Thiazide diuretics, used for hypertension, can exacerbate hyperlipidemia, possibly linked to electrolyte depletion.

Purpose of the Study:

• To investigate the role of hypokalemia in thiazide-induced hyperlipidemia.
• To examine the impact of sodium balance on lipid metabolism during hypertension treatment.

Main Methods:

• Assessed lipid concentrations using a spironolactone-thiazide regimen to prevent potassium loss.
• Measured lipid levels during periods of sodium administration and placebo therapy.
• Conducted a multicenter trial comparing enalapril and indapamide for resistant hypertension.

Main Results:

• Hyperlipidemia persisted despite normal serum potassium levels during spironolactone-thiazide treatment.
• Cholesterol levels decreased during sodium administration.
• Indapamide demonstrated superior antihypertensive potency with minor metabolic effects compared to enalapril.

Conclusions:

• Sodium administration appears to improve lipid metabolism, while sodium diuresis enhances antihypertensive effects.
• Low-dose combination therapy with a diuretic and a nondiuretic agent may improve metabolic tolerance and hypertension control.
• This therapeutic strategy shows promise for optimizing cardiovascular risk reduction.